Kerry Wentworth Flexion Therapeutics Inc (FLXN) insider trading activity

FLXN Quotes by TradingView

Kerry Wentworth is Chief Regulatory Officer of Flexion Therapeutics Inc. Currently has a direct ownership of 0 shares of FLXN, which is worth approximately $0. The most recent transaction as insider was on Nov 19, 2021, when has been sold 140,843 shares (Common Stock) at a price of $8.5 per share, resulting in proceeds of $1,197,166. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Kerry Wentworth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Sale (or disposition) back to the issuer
$1,197,166 $8.5 p/Share
140,843 Reduced 100.0%
0 Common Stock
Jul 19 2021
SELL
Open market or private sale
$25,439 $6.45 p/Share
3,944 Reduced 2.73%
140,362 Common Stock
Jun 21 2021
BUY
Grant, award, or other acquisition
$4,193 $7.78 p/Share
539 Added 0.37%
144,306 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
30,000 Added 17.26%
143,767 Common Stock
Jan 05 2021
SELL
Open market or private sale
$76,007 $11.13 p/Share
6,829 Reduced 5.66%
113,767 Common Stock

Also insider at

NUVB
Nuvation Bio Inc. Healthcare
CHIEF REGULATORY OFFICER
KW

Kerry Wentworth

Chief Regulatory Officer
New York, NY

Track Institutional and Insider Activities on FLXN

Follow Flexion Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FLXN shares.

Notify only if

Insider Trading

Get notified when an Flexion Therapeutics Inc insider buys or sells FLXN shares.

Notify only if

News

Receive news related to Flexion Therapeutics Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FLXN